BackNKGen Biotech Overview

NKGen Biotech EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NKGN.

Quarterly EBIT

$15.86M
308.1% YoY

As of Mar 31, 2025

Annual EBIT (TTM)

$1.19M
104.42% YoY

Trailing 12 months ending Mar 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)